Overview iTrack™ iTrack™ Advance Molteno3®

Overview Team AlphaRET

Overview ASX Announcements Presentations Share Registry Board of Directors Corporate Governance Capital Raise

Presentations

2RT^® – Potential Breakthrough Treatment of Macular Degeneration (AMD)

pdf

15 Oct, 2024

2024 Results Presentation

pdf

26 Aug, 2024

Presentation of FY24 Sales

pdf

8 July, 2024

Investor Presentation February 2024

Link

12 Feb, 2024

Trading Halt

Link

12 Feb, 2024

AGM Presentation 2023

pdf

23 Nov, 2023

Load more

For investor enquires please contact:

Mark Flynn
Nova Eye Medical Limited
W +61 416 068 733
mflynn@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More